Details of the Drug Formulaction

General Information of Drug Formulation (ID: F10013)

• Formulation Name: Hydroxyzine 25 mg capsule
• Company: State of Florida DOH Central Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Hydroxyzine	(DMF8Y74)	Allergic rhinitis	CA08.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C blue no. 1	(E00263)	19700	Colorant
Ferrous oxide	(E00241)	14945	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent